Country eligibility info

Armenia - Horizon Europe Associated Countries

Check if partners from Armenia qualify for Horizon Europe funding

Please note that this information sheet will be updated regularly and the list of countries divided into the different categories can always change over the period of Horizon Europe. If you are involving a partner from a non-EU country in your consortium please always check the status of this country in Horizon Europe at the moment of submission in the Horizon Europe Programme Guide.

Armenia belongs to the group of Horizon Europe Associated Countries

Scroll further to find out what this means exactly

Specific remarks for Armenia

No extra info available

Eligibility for Horizon Europe Associated Countries means...

Short explanation

Association to Horizon Europe is the closest form of international cooperation in Horizon Europe. Entities of Associated Countries can participate in the Horizon Europe calls under the same conditions as entities from the EU Member States and are therefore eligible for funding, unless specific limitations or conditions are laid down in the work programme and/or call topic text.

Not only EU neighbouring countries can apply for association, any country in the world with a strong research and innovation capacity that share common values with Europe can apply for association to Horizon Europe.

There are 4 categories of countries eligible for association with Horizon Europe:

  • (a) European Free Trade Association (EFTA) members which are members of the European Economic Area (EEA)
  • (b) Acceding countries, candidate countries and potential candidates
  • (c) European neighbourhood policy countries
  • (d) Non-EU countries  and territories that fulfil a set of criteria related to their economic, political and research and innovation systems

Close to the start of the Association, transitional measures can be set in place, through which entities of these countries have to be included as beneficiaries in call topics. Details are mentioned in the Horizon Europe Programme Guide.

All details regarding country eligibility is compiled in the infosheet “International cooperation".

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.